Multipotent mesenchymal stromal cells in kidney transplant recipients: The next big thing?
- 1 January 2021
- journal article
- review article
- Published by Elsevier in Blood Reviews
- Vol. 45, 100718
Abstract
No abstract availableKeywords
Funding Information
- Research Foundation Flanders (1842919N)
This publication has 67 references indexed in Scilit:
- Phenotype, donor age and gender affect function of human bone marrow-derived mesenchymal stromal cellsBMC Medicine, 2013
- Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cellsStem Cell Research & Therapy, 2013
- Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-γ licensingCytotherapy, 2012
- Detrimental effects of rat mesenchymal stromal cell pre-treatment in a model of acute kidney rejectionFrontiers in Immunology, 2012
- Autologous Mesenchymal Stromal Cells and Kidney TransplantationClinical Journal of the American Society of Nephrology, 2011
- The PD‐1 pathway in tolerance and autoimmunityImmunological Reviews, 2010
- Inflammatory Cytokine-Induced Intercellular Adhesion Molecule-1 and Vascular Cell Adhesion Molecule-1 in Mesenchymal Stem Cells Are Critical for ImmunosuppressionThe Journal of Immunology, 2010
- PD‐1 signaling in primary T cellsImmunological Reviews, 2009
- Mesenchymal Stem Cells: Revisiting History, Concepts, and AssaysCell Stem Cell, 2008
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006